(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(-0.22%) $82.51
(1.99%) $1.746
(0.25%) $2 394.40
(-0.28%) $28.32
(-0.54%) $949.00
(0.29%) $0.940
(0.50%) $11.05
(0.15%) $0.804
(0.10%) $94.15
Live Chart Being Loaded With Signals
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States...
Stats | |
---|---|
Today's Volume | 8 472.00 |
Average Volume | 40 222.00 |
Market Cap | 24.63M |
EPS | $0 ( 2024-03-18 ) |
Next earnings date | ( $-0.400 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.070 |
ATR14 | $0.0150 (1.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | Adawi Kamal | Sell | 9 297 | Common Stock |
2024-03-04 | Adawi Kamal | Sell | 3 487 | Common Stock |
2024-02-29 | Aballi John | Buy | 9 804 | Common Stock |
2024-02-20 | Adawi Kamal | Buy | 75 000 | Common Stock |
2024-02-20 | Aballi John | Buy | 175 000 | Common Stock |
INSIDER POWER |
---|
81.70 |
Last 95 transactions |
Buy: 1 620 208 | Sell: 654 239 |
Exagen Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Exagen Inc Financials
Annual | 2023 |
Revenue: | $52.55M |
Gross Profit: | $29.46M (56.06 %) |
EPS: | $-1.340 |
Q4 | 2023 |
Revenue: | $13.77M |
Gross Profit: | $8.15M (59.17 %) |
EPS: | $-0.310 |
Q3 | 2023 |
Revenue: | $13.42M |
Gross Profit: | $7.71M (57.44 %) |
EPS: | $-0.310 |
Q2 | 2023 |
Revenue: | $14.14M |
Gross Profit: | $8.30M (58.72 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Exagen Inc
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody and associated vasculitis; AVISE Anti-CarP test, which identifies RA patients with severe disease; and AVISE PC4d to measure platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators